KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Gross Margin (2016 - 2025)

Eli Lilly (LLY) has disclosed Gross Margin for 17 consecutive years, with 82.52% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 28.0% year-over-year to 82.52%, compared with a TTM value of 83.04% through Dec 2025, up 173.0%, and an annual FY2025 reading of 83.04%, up 173.0% over the prior year.
  • Gross Margin was 82.52% for Q4 2025 at Eli Lilly, roughly flat from 82.91% in the prior quarter.
  • Across five years, Gross Margin topped out at 84.27% in Q2 2025 and bottomed at 71.02% in Q2 2021.
  • Average Gross Margin over 5 years is 78.88%, with a median of 79.65% recorded in 2023.
  • The sharpest move saw Gross Margin tumbled -687bps in 2021, then surged 693bps in 2022.
  • Year by year, Gross Margin stood at 74.37% in 2021, then increased by 6bps to 78.8% in 2022, then grew by 3bps to 80.89% in 2023, then rose by 2bps to 82.24% in 2024, then rose by 0bps to 82.52% in 2025.
  • Business Quant data shows Gross Margin for LLY at 82.52% in Q4 2025, 82.91% in Q3 2025, and 84.27% in Q2 2025.